InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,923.20
(
0.39%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,804.85
(
1.72%
)
Post# of 252523
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopearl

Send PM Follow Ignore
Followers 6
Posts 760
Boards Moderated 0
Alias Born 07/18/2006

biopearl

Re: bladerunner1717 post# 162620

Monday, 06/17/2013 11:55:20 AM

Monday, June 17, 2013 11:55:20 AM

Post# of 252523
How do you think this compares with the Incyte/Novartis Comfort 3 data? Seems they are chasing the same goals and Novartis just reported disease modification which was the Geron holy grail. Am a little leery of Geron these days. Also of note was the absence of data from 2 of Geron's PV patients who had been on med for <6mo. I found that troublesome. Any opinions welcome. Thanks, bp
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up